BackgroundCheck.run
Search For

Sheila Xiang Zhou, 621716 Harriman Ln, Redondo Beach, CA 90278

Sheila Zhou Phones & Addresses

6172 Sierra Palos Rd, Irvine, CA 92603    949-9812698   

Eastvale, CA   

Corona, CA   

Redondo Beach, CA   

Torrance, CA   

Tucson, AZ   

Hermosa Beach, CA   

Social networks

Sheila Xiang Zhou

Linkedin

Work

Company: Allergan May 1999 Position: Scientist

Education

School / High School: University of Arizona

Skills

Drug Discovery • Molecular Biology • Cell Culture • Assay Development • In Vivo • Elisa • Cell Biology • Protein Chemistry • Biotechnology • Life Sciences • Drug Development • In Vitro • Pharmaceutical Industry • Cell • Clinical Development • Lifesciences

Languages

English • Mandarin

Industries

Pharmaceuticals

Mentions for Sheila Xiang Zhou

Sheila Zhou resumes & CV records

Resumes

Sheila Zhou Photo 11

Scientist

Location:
Sparks, NV
Industry:
Pharmaceuticals
Work:
Allergan
Scientist
La Biomed – Los Angeles Biomedical Research Institute Nov 1995 - Apr 1999
Staff Research Associate
University Heart Center University of Arizoan Mar 1993 - Sep 1995
Research Specialist
Education:
University of Arizona
Peking University
Skills:
Drug Discovery, Molecular Biology, Cell Culture, Assay Development, In Vivo, Elisa, Cell Biology, Protein Chemistry, Biotechnology, Life Sciences, Drug Development, In Vitro, Pharmaceutical Industry, Cell, Clinical Development, Lifesciences
Languages:
English
Mandarin

Publications & IP owners

Us Patents

Methods For Treating Diseases Of The Retina

US Patent:
2012014, Jun 7, 2012
Filed:
Nov 16, 2011
Appl. No.:
13/298028
Inventors:
Jyotirmoy Kusari - Irvine CA, US
Sheila X. Zhou - Irvine CA, US
Mingting Tian - Irvine CA, US
Edwin U. Padillo - Orange CA, US
Sandhya S. Rao - Irvine CA, US
Daniel W. Gil - Corona Del Mar CA, US
Larry A. Wheeler - Irvine CA, US
Assignee:
ALLERGAN, INC. - Irvine CA
International Classification:
A61K 31/5513
A61P 35/00
A61P 27/02
US Classification:
514220
Abstract:
Disclosed herein is a method of treating disorders of the retina comprising administering to a patient in need of such treatment a compound selected from the group consisting of olanzapine, certain of its metabolites, clozapine, and n-desmethyl clozapine.

Stable Rxr Expressing Cell Line

US Patent:
2003022, Dec 11, 2003
Filed:
May 8, 2001
Appl. No.:
09/850835
Inventors:
Jyotirmoy Kusari - Irvine CA, US
Sheila Zhou - Irvine CA, US
Hongzhi Liu - Irvine CA, US
Ramilla Lewis - Lake Forest CA, US
Roshantha Chandraratna - Laguna Hills CA, US
Assignee:
Allergan Sales, Inc.
International Classification:
G01N033/53
G01N033/567
C07K014/705
US Classification:
435/007200, 435/325000, 530/350000
Abstract:
Stable cell lines which express retinoid receptors and the insulin receptor are prepared and are useful in identifying agonists and antagonists of retinoid receptors. Agonists and antagonists of the RXR receptor can be determined using the cell lines of the invention which are producers of RXR alone; agonists and antagonists of other retinoid receptors can be determined using cell lines transfected with RXR and the desired retinoid receptor.

Methods For Treating Diseases Of The Retina

US Patent:
2015029, Oct 15, 2015
Filed:
Apr 27, 2015
Appl. No.:
14/696789
Inventors:
- Irvine CA, US
Sheila X. Zhou - Irvine CA, US
Mingting Tian - Irvine CA, US
Edwin U. Padillo - Orange CA, US
Sandhya S. Rao - Irvine CA, US
Daniel W. Gil - Corona Del Mar CA, US
Larry A. Wheeler - Irvine CA, US
International Classification:
A61K 31/5513
A61K 31/551
Abstract:
Disclosed herein is a method of treating disorders of the retina comprising administering to a patient in need of such treatment a compound selected from the group consisting of olanzapine, certain of its metabolites, clozapine, and n-desmethyl clozapine.

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.